Delivery Order SPE2DB24D1021-SPE2DB24FESCE
Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $61,930.93 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of STELARA 90 MG/ML syringes to support medical supply requirements. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and...
- This is a $37,303.69 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the supply of STELARA 90 MG/ML SYRINGE, a specialty medication, with a period of performance through July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling of up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
- This is a $36,992.14 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565392041 STELARA 90 mg/ml syringes, with an ultimate completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of...
- This is a $25,636.53 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for the supply of STELARA 90 MG/ML SYRINGE, a specialty pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities...
- This is a $43,152.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, with a completion date of December 12, 2024. This delivery order is placed under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, which...
- This is a $8,037.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 45 mg/0.5 mL STELARA syringes. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides global pharmaceutical support to military healthcare programs through December 2026. This delivery order does not have a...
- This is a $31,913.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $11,743.23 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded by the DLA to Amerisourcebergen, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
- This is a $21,966.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a $28,341.07 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB24FESCEDelivery Order
This is a $29,039.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of STELARA 90 MG/ML syringes. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by June 13, 2024.
Generated 11/1/24, 10:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.0k | 6/12/24 |